Company Overview of iNtRON Biotechnology, Inc.
iNtRON Biotechnology, Inc., a bio new drug company, develops, manufactures, and commercializes bio-medicines targeting infectious diseases. The company offers super bacteria drugs, such as Sal 200 and NPA 200; cancer treating drug delivery media; heme-iron supplements, antibiotic alternative products for animals; and various lab reagents and kits, as well as nucleic acid tests for new flu, VRE super bacteria, food poison, and Al. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea.
#701~704, 505, 903 JungAng Induspia
Founded in 1999
82 3 1739 5678
82 3 1739 7246
Key Executives for iNtRON Biotechnology, Inc.
iNtRON Biotechnology, Inc. does not have any Key Executives recorded.
iNtRON Biotechnology, Inc. Key Developments
Similar Private Companies By Industry
|AptaBio Therapeutics Inc.||Asia|
|Anterogen Co., Ltd.||Asia|
|SNP Genetics Inc.||Asia|
Recent Private Companies Transactions
July 20, 2015
|Shandong Baolai-Leelai Bio-Industrial Group Ltd.|
To contact iNtRON Biotechnology, Inc., please visit www.intron.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.